BANK OF AMERICA CORP /DE/ - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 44 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$360
+531.6%
282
+63.0%
0.00%
Q2 2023$57
-33.7%
173
-13.5%
0.00%
Q1 2023$86
+6.2%
200
+31.6%
0.00%
Q4 2022$81152
+50.5%
0.00%
Q3 2022$0101
-74.8%
0.00%
Q2 2022$0401
+297.0%
0.00%
Q1 2022$0101
-43.6%
0.00%
Q4 2021$0
-100.0%
179
-55.4%
0.00%
Q3 2021$2,0000.0%401
-4.3%
0.00%
Q2 2021$2,000
-33.3%
419
-21.1%
0.00%
Q1 2021$3,000531
+425.7%
0.00%
Q4 2020$01010.0%0.00%
Q3 2020$0
-100.0%
101
-99.3%
0.00%
Q2 2020$46,000
+31.4%
13,639
+48.8%
0.00%
Q1 2020$35,000
-98.3%
9,163
-97.3%
0.00%
Q4 2019$2,024,000
+693.7%
335,091
+893.9%
0.00%
Q3 2019$255,000
+61.4%
33,715
+189.7%
0.00%
Q2 2019$158,000
+5166.7%
11,639
+2227.8%
0.00%
Q1 2019$3,000
+200.0%
500
+100.0%
0.00%
Q4 2018$1,000
-83.3%
250
-68.4%
0.00%
Q3 2018$6,000
-91.7%
792
-89.2%
0.00%
Q2 2018$72,000
+500.0%
7,361
+470.6%
0.00%
Q1 2018$12,000
-42.9%
1,290
-24.3%
0.00%
Q4 2017$21,000
-48.8%
1,704
-65.3%
0.00%
Q3 2017$41,000
+1266.7%
4,904
+2427.8%
0.00%
Q2 2017$3,000
-96.6%
194
-95.6%
0.00%
Q1 2017$89,000
+1171.4%
4,410
+333.2%
0.00%
Q2 2016$7,000
+600.0%
1,018
+1126.5%
0.00%
Q4 2015$1,000830.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 3,662,342$7,874,0000.16%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 213,469$438,0000.07%
GSA CAPITAL PARTNERS LLP 150,914$309,0000.04%
Bernardo Wealth Planning LLC 30,469$62,0000.03%
Penserra Capital Management LLC 351,154$719,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,900$361,0000.01%
Founders Capital Management 3,000$9,0000.01%
King Wealth Management Group 16,000$33,0000.01%
Aquatic Capital Management LLC 1,900$4,0000.01%
Newbridge Financial Services Group, Inc. 6,075$12,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders